🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementFAERS pharmacovigilance data for semaglutide — looking for input Page 3

FAERS pharmacovigilance data for semaglutide — looking for input

B12Beth Thu, Nov 13, 2025 at 6:51 AM 11 replies 898 viewsPage 3 of 3
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Nov 13, 2025 at 11:06 AM#11
Dr.GutHealth said:
FAERS pharmacovigilance data for is not that straightforward in my experience

This is exactly right. Dr.GutHealth articulated what I have been trying to explain to my doctor for months. The FAERS pharmacovigilance aspect is the most important factor.

Last edited: Nov 13, 2025 at 1:06 PM
12 22PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 9 others
Reply Quote Save Share Report
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Nov 13, 2025 at 11:23 AM#12

Reading this thread on FAERS pharmacovigilance hits close to home. Night shift nurse — I started at 275 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 50 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about FAERS pharmacovigila — take the leap. It was the best health decision I have ever made. ❤️

19 14TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 16 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Nov 13, 2025 at 11:40 AM#13

newstart_MO — that is really helpful context on FAERS pharmacovigilance. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Nov 13, 2025 at 5:40 PM
41 0kevin_tulsa, Dr.PainCLE, mike_mealprep and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Nov 13, 2025 at 11:57 AM#14

To answer ChrisMacros's question specifically:

From a clinical standpoint, FAERS pharmacovigilance data is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

30 12Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 27 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Nov 13, 2025 at 12:14 PM#15

Bookmarked 📌 The FAERS pharmacovigila info in this thread is essential. Coming back to this for sure.

38 2amy_econ_NJ, bbq_ray_KC, oliver_london and 35 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register